Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: Lessons learned from human papillomavirus DNA testing

Cancer

Volumn 111, Issue 3, 2007, Pages 160-165

  Johnston, Elizabeth I ^a   Logani, Sanjay ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Atypical squamous cells of undetermined significance; Cervical cytology; Human papillomavirus testing; Perimenopausal

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; ATYPICAL SQUAMOUS CELL OF UNDETEMINED SIGNIFICANCE; CELL NUCLEUS; CLIMACTERIUM; CYTODIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POSTMENOPAUSE; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CHILD; CYTODIAGNOSIS; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; PERIMENOPAUSE; POSTMENOPAUSE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34250808643     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22687     Document Type: Article

References (23)

1. Castle PE, Schiffman M, Herrero R, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis. 2005;191:1808-1816.
2. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92:464-474.
3. Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412-420.
4. Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. 2003;127:930-934.
5. Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, van den Brule AJ. Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis. 2000;27:438-445.
6. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. 1941. Arch Pathol Lab Med. 1997;121:211-224.
7. Apgar BS, Brotzman G. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear. Am Fan Physician. 1999;59:2794-2801.
8. Cox JT. Management of atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion by human papillomavirus testing. Best Pract Res Clin Obstet Gynaecol. 2001;15:715-741.
9. Davey DD, Zarbo RJ. Human papillomavirus testing - are you ready for a new era in cervical cancer screening? Arch Pathol Lab Med. 2003;127:927-929.
10. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
11. Schiffman M, Solomon D. Findings to date from the ASC-US-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003;127:946-949.
12. Keating JT, Wang HH. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women. Cancer (Cancer Cytopathol). 2001;93:100-105.
13. Saminathan T, Lahoti C, Kannan V, Kline TS. Postmenopausal squamous-cell atypias: a diagnostic challenge. Diagn Cytopathol. 1994;11:226-230.
14. Abati A, Jaffurs W, Wilder AM. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer (Cancer Cytopathol). 1998;84:218-225.
15. Menezes GA, Wakely PE Jr, Stripe DM, Nuovo GJ. Increased incidence of atypical Papanicolaou tests from ThinPreps of postmenopausal women receiving hormone replacement therapy. Cancer (Cancer Cytopathol). 2001;93:357-363.
16. Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP. Postmenopausal squamous atypia: a spectrum including "pseudo-koilocytosis". Mod Pathol. 1995;8:408-112.
17. Petignat P, Faltin D, Goffin F, et al. Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinoma. Cancer (Cancer Cytopathol). 2005;105:126-132.
18. Eltoum IA, Chhieng DC, Roberson J, McMillon D, Partridge EE. Reflex human papillomavirus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women. Cancer (Cancer Cytopathol). 2005;105:194-198.
19. Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ. 2006;332:83-85.
20. Layfield LJ, Qureshi MN. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASC-US): cost comparison of two methods. Diagn Cytopathol. 2005;33:138-143.
21. Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med. 2003;127:940-945.
22. Seabrook JM, Hubbard RA. Achieving quality reproducible results and maintaining compliance in molecular diagnostic testing of human papillomavirus. Arch Pathol Lab Med. 2003;127:978-983.
23. Kulasingam SL, Kim JJ, Lawrence WF, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst. 2006;98:92-100.